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INTRODUCTION
A variety of cytological studies have produced the
concept that the antimitotic drugs colchicine
and Colcemid bind to specific proteins, the
"tubulins" (1, 3, 4, 20, 38, 42) . Moreover it has
been implied in most of these studies that these
"colchicine-binding proteins" are recovered in a
soluble form, i.e., in the 100,000 g supernate
from a cellular homogenate . However, recently,
colchicine-binding has been described for par-
ticulate cellular subfractions from various tissues,
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especially in membrane fractions from mam-
malian brain and liver (6, 8, 25, 26, 36, 42) . The
colchicine-binding capability is different in the
various membranes and seems to be especially
high, for example, in nuclear membranes from
mammalian liver and microsomes and synaptic
membranes from mammalian brain . The occur-
rence of colchicine-binding proteins in such a
particle-bound form has been alternatively
explained as due to (a) the association of tubulin
with such membranes (8, 36) or (b) that colchicine
297and related drugs can also be bound by nontubu- (d) incubation temperature, from 0•C to 90,•C, with
lin membrane components. The present study or without preincubation at 906640r, 30 mina Bound
extends our earlier investigations on the localiza- colchicine was determined '(sy` the "filter technique
tion and distribution of colchicine-binding sites in according to Weisenberg et' al .' (38 ; for details see
liver and brain cell fractions and will present some also refs. 2 and 35). In some experiments designed
differences in the binding characteristics of tubu- to study the strength of the binding, 'we allowed the
Tins and membranes. It suggests that, in contrast bound colchicine to equilibrate with the wash me-
dium, in each of the six wash steps, for 10 min at
to the association of tubulin with brain membrane room temperature . When membranous material was
fractions, much of the binding to liver membrane- assayed, this method was routinelj compared with
fractions is nonspecific. that of the repeated washes by ultracentrifugation
(36) and with the method of Feit and Barondes (8),
which uses a centrifugation through 10% sucrose
(in our experiments this step was followed by a cen-
trifugation for 30 min at 160,000 g) . If not otherwise
indicated, the determinations of the bound drug
represent the differences of the amounts bound in the
specific probe and that in the corresponding zero
time and 0•C "blank." All wash steps were carried
out at 4•C, except in determinations of the tempera-
ture dependence of the binding in which the washes
were done at the incubation temperatures (20-60•C) .
Protein was determined by the method of Lowry et
al. (27). The radioactivity bound on the filter papers
was counted in 10 ml toluene based scintillation
fluid, containing 1 ml NCS (Nuclear Chicago Solu-
bilizer, Amersham/Searle Corp., Arlington Heights,
Ill.) in a liquid scintillation counter at an efficiency
of 40% for 3H and 85% for 14C-labeled material.
MATERIALS AND METHODS
Brains of young albino rats (Wistar II, 150 g) and
mice (N. M. R. I. BR 66, 16-20 g) were freed from
meninges, surface blood capillaries etc ., and were
immediately homogenized by several strokes with a
glass-Teflon Potter-Elvehjem homogenizer in the
assay medium (3 ml per brain) containing 0.01 M
MgCl2, 10-4 M guanosine triphosphate (GTP) in
0.01 M potassium phosphate buffer, the whole ad-
justed to a final pH of 6.8. This homogenate was
centrifuged at 100,000 g for I h at 4 •C to separate
the "100,000 g supernate" and the "brain particu-
late fraction." From rat liver homogenate (in 0 .4 M
sucrose, 0.07 M KCI, 2% gum arabic, 0.01 M Tris,
pH 7.2) recovery studies were performed in the
crude fractionation indicated in Fig. 1 . . Purified
nuclei, nuclear membranes, and microsomes were
also prepared from rat and mouse liver homogenates
(15, 21). Sonication of membrane proteins was per-
formed with a Branson Sonifier (Branson Instru-
ments Co., Stamford, Conn.) equipped with a
microtip at low power for 2-6 X 30 s in 2 ml (cooled
by a crushed ice water mixture) . [3H]- or [14C]-
colchicine (sp act 5.7 Ci/mmol and 15 mCi/mmol)
and [3H]Colcemid (sp act 21 Ci/mmol) were pur-
chased from New England Nuclear (Boston, Mass .).
Lumicolchicine was prepared by exposure of col-
chicine to UV light (350 nm, 8 watt) in 95% ethanol
(43) for 20 min, separated by thin layer chromatogra-
phy (silicagel G, CC13/MeOH 95 :5, vol/vol), and
identified by its maxima at 228 and 266 nm (com-
pared to those at 247 and 350 nm in colchicine ; 11,
43). Radiochemical purity and possible chemical
alterations of the radioactive drugs were checked by
scanning the thin-layer chromatograms with a gas-
flow-counter and comparing the mobilities with that
of unlabeled colchicine (35). After the assay the bound
radioactivity was reisolated (3, 8) and identified in
the same way. The incubation was carried out in the
"assay medium" under gentle magnetic stirring .
The following parameters were varied : (a) protein
concentrations from 0 .2 to 5 mg/ml ; (b) colchicine
concentrations from 10-9 to 10-a M (by adding
unlabeled colchicine ; E. Merck AG, Darmstadt,
Germany) ; (c) incubation time from 0 min to 6 h ;
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RESULTS
Membrane and nuclear fractions from rat liver
have a significant colchicine-binding activity as
detected both by binding assays (36) and auto-
radiography (18) . A recovery study of colchicine-
binding capacity through crude fractions from
homogenized rat liver is shown in Fig . 1, demon-
strating the remarkable amount and the specific
activity (per milligram protein) of drug binding,
especially in the membrane fractions . When we
compared the binding activities of nuclear and
microsomal membranes prepared in parallel at
different protein concentrations over a range of
0.3-3.0 mg/m1, using the "centrifugation method"
(36), the nuclear membranes consistently bound
more colchicine than the microsones (Fig. 2),
and, likewise, more than rat liver plasma mem-
branes prepared according to Ray (32) . When the
membrane fractions were depleted and extracted
of lipids according to Fleischer et al. (10), the
efficiency of binding colchicine was not signifi-
cantly diminished (35) . This is in accord with the
view that it is membrane protein which binds the
drug and rules out any preferential partition into
the membrane lipids as the explanation for the50
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membrane binding of colchicine. The binding of
colchicine to membranes from the endoplasmic
reticulum and the nuclear envelope strongly in-
creases with temperature (see below) but is dif-
ferent from the binding to brain supernatant
protein or to purified tubulin by not reaching
saturation in a range from 10-9 M to 10--2 M.
Fig. 3 shows the binding curves in between 10-8 M
and 10-4 M. When one plots the binding data of
colchicine to brain supernatant protein :and liver
nuclear membranes and microsomes according to
Scatchard (33 ; reviews in 22, 23, and 37), one sees
that the brain supernatant protein exhibits a
normal: "tubulin-like" binding characteristic
with ca. 6 X 1014 effective binding . sites per mg
protein (Fig. 4; compare, e.g., refs: 30, 38, 42)
whereas the curves for the : membrane fractions
are significantly different. The microsomes did
not show any specific binding, even at low con-
centrations. The nuclear membranes, however,
revealed a complex curve suggesting either nega-
tive cooperativity or heterogeneity of binding
sites (compare, e.g., 24) . Due to the complicated
situation a definite value for the number of specific
binding sites per milligram of protein (n M) cannot
be obtained from the curve . The binding of
colchicine to nuclear and microsomal membranes
is relatively stable. -as demonstrated -in repeated
washes with assay medium, using both the filter
assay and the centrifugation method . After re-
moval of the unbound colchicine, i .e. from the
third wash on, the loss of radioactivity from the
membrane fractions was, in our hands, compa-
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FIGURE 1 Recovery study of colchicine binding in crude fractions from the rat liver homogenate after
centrifugation at 1,500 g (15 min), 10,000 g (10 min), and 100,000 g (1 h) . The colchicine binding of the
pellets sequentially obtained ("nuclei," hatched blocks ; "mitochondria," dotted blocks ; "microsomes,"
blank blocks) and the "100,000 g supernatant" (cross-hatched blocks) is demonstrated as total colchicine
binding per fraction (left), and as specific binding activity per protein content (right). In vitro incubation
was carried out at 87•C for I h with 5 X 10-7 M [8H]colchicine at a protein concentration of 5 mg/ml.
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FIGURE 2 Binding of colchicine by rat liver micro-
somes (O) and nuclear membranes (°) at different
protein concentrations after in vitro incubation in
10-4M [ 14Cjcolchicine for 1 h at 37 •C.
rable to that of the brain supernatant tubulin :
each additional wash resulted in a loss of ca. 5%.
The colchicine-binding activity of tubulin in the
brain supernate is heat sensitive (total destruction
at 60•C; cf. refs. 5 and 42) . In contrast to this,
the membranes studied are even enhanced in
colchicine-binding activity when incubated at
°
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FIGURE 3 Colchicine binding to rat liver microsomes
as a function of time for various molar concentrations
of colchicine (indicated for each curve) at a constant
protein concentration (10 mg/ml) after incubation at
37°C (-) and 0°C (- - -), using both [3H]- and [14C]-
colchicine.
higher temperatures or after preheating at 90 °C
for 30 min (Fig. 5) . However, the temperature
during the wash procedures has also a marked
effect on the amount of colchicine bound : higher
temperatures render more colchicine released .
Extensive sonication before the binding assay
leads to a slight (approximate 1 .5-fold) increase
of colchicine binding (for details see 35) . It is
excluded, however, that the specific difference
between the nuclear membranes and the other
membranes studied, especially the microsomes, is
merely due to an increased membrane surface
ratio, since the nuclear membrane fragments, as
we prepare them, are larger than the correspond-
ing microsomes (see, e.g., refs. 15 and 21).
Inr order to characterize the binding to the
membrane structures, we compared the colchicine
binding with the capacity to bind lumicolchicine
which is biologically inactive and not bound by
tubulin (42) . In our assays lumicolchicine was not
bound by the brain 100,000 g supernatant pro-
teins (35, see also ref. 8) . All the brain fractions
101-
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FIGURE 4 Scatchard plot for binding of colchicine
to rat liver microsomes (O) and nuclear membranes
(0) and rat brain 100,000 g supernate (A). nM indi-
cates the maximal number of moles colchicine bound
per milligram brain supernatant protein . Incubation
was, carried out at 37°C for 90 min in the "assay
medium." Each value is an average from at least four
experiments.
bound much more colchicine than lumicolchicine
but the ratio of lumicolchicine to colchicine
binding is significantly higher in the brain "par-
ticulate fraction" (Fig . 6) . With the liver fractions,
however, the microsomes bound nearly equal
amounts of colchicine and lumicolchicine, and
the nuclear membranes were consistently even
slightly more effective in binding lumicolchicine.
When one plots the differences of bound colchicine
and lumicolchicine as a function of the time of
incubation, one obtains curves characteristic of
the various fractions assayed as shown in Fig . 7.
While the relatively poor colchicine-binding
activity contained in a rat liver 100,000g supernate
which had been "directly" prepared from the
homogenate by a single centrifugation (i.e., in a
manner identical to that used for the brain super-
natant protein) had a binding behaviour indica-
tive of some tubulin-like specificity (Fig. 7), the
microsomes and nuclear membranes showed
neither specific binding nor did the difference ofI
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FIGURE 5 Colchicine binding to microsomes as func-
tion of the incubation temperature after preheating
at 90°C during 30 min (O) or without preheating (A).
Washes were carried out, as usual, in the cold (4°C) .
The third curve (•) shows the effect of washing at
different incubation temperatures (at 4, 90, or 60 °C)
using the preheated microsomes .
colchicine and lumicolchicine binding reveal the
pronounced "late" saturation typical for tubulin
(compare 4, 5, 39) . In some cell systems Colcemid
is more effective in mitotic arrest as well as in
binding to tubulin (e.g. 20). When we examined
the binding of Colcemid to the liver nuclear
membrane and microsomal fractions, we did not
note a difference, in comparison with colchicine,
in the Scatchard plot curves. While the binding
(per milligram protein) of Colcemid was not
significantly different from that of colchicine in
the microsomes, the nuclear membranes were
more effective in binding Colcemid by a factor
varying from 1 .5 to 2.0.
DISCUSSION
The results confirm and extend the earlier demon-
strations that membrane material can bind colchi-
cine and Colcemid in a relatively stable mode (6,
8, 20, 25, 26, 36, 42) . The presence of such mem-
branous binding sites is also indicated to us in
the data of Gillespie (19; her "particulate bound
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FIGURE 6 Specific binding activities of rat brain
homogenate (0), 100,000 g pellet (O), and 100,000 g
supernate (A) in binding colchicine (-) and lumi-
colchicine (--- ).
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FIGURE 7 Comparison of the specificity of colchicine
binding of rat brain 100,000 g supernate (A) with
100,000 g supernate (A), microsomes (o), plasma
membranes (49), and nuclear membranes (O) from rat
liver plotted as the differences of colchicine and lumi-
colchicine bound per milligram protein in aliquots .
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-5colchicine") who studied the colchicine binding
using tissue slices. Our data further add to the
indications that different types of membranes vary
in their binding activity, particularly high ac-
tivity being associated with nuclear membranes
from mammalian liver and with nerve ending
and synaptosomal fractions (see the references
mentioned above and ref. 9) . The existence of
some colchicine-binding sites in membranes might
also be expected from the existence of enzymes in
the microsomal membranes of liver, which are
capable of hydroxylation and degradation of
colchicine (34), and from the inhibitory effects of
colchicine (but also of lumicolchicine) on the
transport of nucleosides across the plasma mem-
branes of various cultured cells (28) . However, in
contrast to the colchicine binding in membrane-
containing fractions from brain tissue (8), the
binding to the liver membranes differs in a series
of characteristics from its binding to tubulin.
Such differences are the heat stability, its de-
pendence on drug concentration over a range of
10-8-10-'2 M, and its nonspecificity as indicated
by the extremely low ratios of colchicine binding
compared to the binding of lumicolchicine . Some
of the properties of such a membranous colchicine
binding could suggest a contribution by (prob-
ably hydrophobic) membrane surface adsorption,
for example, its increase after sonication and after
membrane disintegration through preheating (see
also ref. 22) . However, increase of binding ac-
tivity by heating of membranes should not be con-
sidered a priori as indication of a nonspecific
adsorption as has been shown for the high affinity
binding sites of cytochrome to mitochondrial
membranes (40) . The complex Scatchard plot of
the nuclear membranes might indicate the pres-
ence of one component with higher affinity super-
imposed on a low affinity and nonspecific binding
(Fig. 4) .
In a diversity of cellular situations microtubules
exhibit a close relationship with membranes,
especially the nuclear membranes, and sometimes
even seem to have their origin where membrane
breakdowns occur (e.g. 7, 14, 16, 17, 31, 41) . This
had led to concepts of membrane-associated foci
nucleating assemblies of microtubules (12, 13, 29,
31, 36) . Although our data demonstrate that the
vast part of the membrane colchicine binding
cannot be explained by the existence of tubulin
in these membranes, they do, on the other hand,
not rule out in general the occurrence of mem-
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brane-associated tubulin. From a crude estima-
tion, however, assuming that all colchicine-bind-
ing sites of membrane tubulin would be accessible,
it is clear that only a minute amount of the mem-
brane proteins in rat liver could be constituted by
such a proposed microtubular membrane com-
ponent (for different situation in brain membrane
fractions see ref. 9).
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